PG vs SKYE · P/E 25, rev $84.28B vs $25.0M cap
Procter & Gamble Company (PG) versus Skye Bioscience, Inc. Common Stock (SKYE) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Skye Bioscience, Inc. Common Stock (SKYE) is a biotechnology company listed on NASDAQ.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
SKYE does not have a complete income-statement cache yet.
PG currently screens at market cap $373.53B and trailing P/E 25.3. SKYE currently screens at market cap $25.0M.
Not investment advice. Open the PG and SKYE stock pages for the full models.
Not investment advice.